Strategic researches on green mine construction are of great theoretical and practical significance to the sustainable development of China's mining industry as well as the great-leap-forward development strategies of China. Strategies of green mine construction in China are methods summarized to solve all potential problems from mine production to ecological restoration. At present, strategies of green mine construction in China are not fully evaluated and studied yet. Therefore, on the basis of green mine construction related literatures carried out by researchers in China and abroad, this study took the green mine of Yongcheng City in China as the research object to evaluate the current situation of green mine construction in Yongcheng City and put forward corresponding countermeasures. First of all, driving force-pressure-state-impact-response (DPSIR) model was introduced for the construction of evaluation index system; construction principles and selection methods of indexes and the index system based on driving force, pressure, state, impact and response were constructed. Secondly, principal component analysis (PCA) was adopted to calculate and evaluate data of green mine of Yongcheng City in recent years, and construction state of green mine in Yongcheng City was analyzed concretely according to the evaluation results. Empirical results showed that, the evaluation system constructed in this study was feasible, which could be applied to evaluate construction of green mine effectively.

There is currently a lack of pathologic data on the novel coronavirus (SARS-CoV-2) pneumonia, or COVID-19, from autopsy or biopsy. Two patients who recently underwent lung lobectomies for adenocarcinoma were retrospectively found to have had COVID-19 at the time of surgery. These two cases thus provide important first opportunities to study the pathology of COVID-19. Pathologic examinations revealed that, apart from the tumors, the lungs of both patients exhibited edema, proteinaceous exudate, focal reactive hyperplasia of pneumocytes with patchy inflammatory cellular infiltration, and multinucleated giant cells. Hyaline membranes were not prominent. Since both patients did not exhibit symptoms of pneumonia at the time of surgery, these changes likely represent an early phase of the lung pathology of COVID-19 pneumonia.

Data on pathologic changes of the 2019 novel coronavirus disease (COVID-19) are scarce. To gain knowledge about the pathology that may contribute to disease progression and fatality, we performed post-mortem needle core biopsies of lung, liver, and heart in four patients who died of COVID-19 pneumonia. The patients’ ages ranged from 59 to 81, including 3 males and 1 female. Each patient had at least one underlying disease, including immunocompromised status (chronic lymphocytic leukemia and renal transplantation) or other conditions (cirrhosis, hypertension, and diabetes). Time from disease onset to death ranged from 15 to 52 days. All patients had elevated white blood cell counts, with significant rise toward the end, and all had lymphocytopenia except for the patient with leukemia. Histologically, the main findings are in the lungs, including injury to the alveolar epithelial cells, hyaline membrane formation, and hyperplasia of type II pneumocytes, all components of diffuse alveolar damage. Consolidation by fibroblastic proliferation with extracellular matrix and fibrin forming clusters in airspaces is evident. In one patient, the consolidation consists of abundant intra-alveolar neutrophilic infiltration, consistent with superimposed bacterial bronchopneumonia. The liver exhibits mild lobular infiltration by small lymphocytes, and centrilobular sinusoidal dilation. Patchy necrosis is also seen. The heart shows only focal mild fibrosis and mild myocardial hypertrophy, changes likely related to the underlying conditions. In conclusion, the post-mortem examinations show advanced diffuse alveolar damage, as well as superimposed bacterial pneumonia in some patients. Changes in the liver and heart are likely secondary or related to the underlying diseases.